Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70707 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Anh M To und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, My Duc Hospital, Ho Chi Minh City, Vietnam. Hauptthemen laut MEDLINE: Magnesium Sulfate, Pre-Eclampsia, Anticonvulsants, Eclampsia. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate serum magnesium concentrations in pregnant women with severe pre‐eclampsia being treated with a novel magnesium sulfate regimen for seizure prevention.
Methods
This was a prospective, longitudinal study. Pregnant women aged 18 years or older with severe pre‐eclampsia and an indication for treatment with magnesium sulfate were included. Participants received a magnesium sulfate loading dose of 4.5 g over 20 min, then a maintenance dose of 1.5 g/h (the standard regimen at the study center). Serum magnesium concentrations were measured at admission, 30 min, 1, 2, 4, and 6 h, then every 6 h until treatment was stopped. Median (interquartile range [IQR]) serum magnesium concentrations are reported. The primary outcome was serum magnesium concentrations during magnesium sulfate infusion.
Results
Serum magnesium concentrations at admission and after 30 min were 0.77 (IQR 0.72–0.82) and 1.81 (IQR 1.63–1.97) mmol/L, respectively. After 4 h, the concentration had decreased slightly to 1.79 (IQR 1.58–2.02) mmol/L. By 12 h, magnesium levels had stabilized at 2 mmol/L. At this time, 50.9% (28/55) had achieved therapeutic magnesium levels (2.0–3.5 mmol/L), and this proportion had increased to 61.7% (29/47) by 24 h. Magnesium toxicity was observed in three patients (4.7%). No cases of eclampsia or maternal mortality were recorded.
Conclusions
This magnesium sulfate regimen was generally well tolerated and also prevented seizures even though serum magnesium levels at 24 h were below the currently defined therapeutic range in at least one‐third of participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, My Duc Hospital, Ho Chi Minh City, Vietnam.
- HOPE Research Center, My Duc Hospital, Ho Chi Minh City, Vietnam.
- Department of Obstetrics and Gynecology, My Duc Phu Nhuan Hospital, Ho Chi Minh City, Vietnam.
- Department of Obstetrics and Gynecology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
ORCID-Profile: Anh M To, Minh H N Nguyen, Tri C Nguyen, Trung Q Bui, Yen T H Dao, Thanh V Le, Thao V Ngo, Toan D Pham, Tuong M Ho, Lan N Vuong
Zitieren
APA
To, A. M., Nguyen, M. H. N., Nguyen, T. C., Bui, T. Q., Dao, Y. T. H., Le, T. V., Ngo, T. V., Pham, T. D., Ho, T. M., & Vuong, L. N. (2025). Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70707
Vancouver
To AM, Nguyen MHN, Nguyen TC, Bui TQ, Dao YTH, Le TV, et al. Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70707
BibTeX
@article{To2025,
author = {To, Anh M and Nguyen, Minh H N and Nguyen, Tri C and Bui, Trung Q and Dao, Yen T H and Le, Thanh V and Ngo, Thao V and Pham, Toan D and Ho, Tuong M and Vuong, Lan N},
title = {Alternative dosing regimen of magnesium sulfate for prevention of eclampsia: An observational prospective study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70707}
}
EUVIMED